Sponsors say the provision would establish uniform, national labeling and
warning requirements for cosmetics and over-the-counter drugs to give
consumers the same information, regardless of what state they're in.
But states could also petition the FDA for exemptions.
"It doesn't make sense to impose up to 50 different labels in 50
different states," said Mike Petrina, vice president for legislative
relations at the Cosmetic, Toiletry and Fragrance Association.
The provision would also apply to nonprescription drugs, but Kennedy is
less concerned about its impact in that area.
Kennedy, who spent several hours criticizing the
provision yesterday, said that the nonpartisan General Accounting Office,
the investigative branch of Congress, nonpartisan General Accounting Office,
the investigative branch of Congress, had identified more that 125
ingredients available for cosmetics that are suspected of causing
cancer. Others may cause birth defects.